Listing 1 - 5 of 5 |
Sort by
|
Choose an application
The first report that rapid eye movements occur in sleep in humans was published in 1953. The research journey from this point to the realization that sleep consists of two entirely independent states of being (eventually labeled REM sleep and non-REM sleep) was convoluted, but by 1960 the fundamental duality of sleep was well established including the description of REM sleep in cats associated with “wide awake” EEG patterns and EMG suppression. The first report linking REM sleep to a pathology occurred in 1961 and a clear association of sleep onset REM periods, cataplexy, hypnagogic hallucinations and sleep paralysis was fully established by 1966. When a naïve individual happens to observe a full-blown cataplexy attack, it is both dramatic and unnerving. Usually the observer assumes that the loss of muscle tone represents syncope or seizure. In order to educate health professionals and the general public, Christian Guilleminault and I made movies of full-blown cataplectic episodes (not an easy task). We showed these movies of cataplexy attacks to a number of professional audiences, and were eventually rewarded with the report of a similar abrupt loss of muscle tone in a dog. We were able to bring the dog to Stanford University and with this as the trigger, we were able to develop the Stanford Canine Narcolepsy Colony. Breeding studies revealed the genetic determinants of canine narcolepsy, an autosomal recessive gene we termed canarc1. Emmanuel Mignot took over the colony in 1986 and began sequencing DNA, finally isolating canarc1 in 1999.
Orexins. --- Hypothalamic hormones. --- Hypothalamus --- Neurohormones --- Neuropeptides --- Hypocretins --- Hypothalamic hormones --- Neurosciences. --- Endocrinology. --- Neurology. --- Medicine --- Nervous system --- Neuropsychiatry --- Internal medicine --- Hormones --- Neural sciences --- Neurological sciences --- Neuroscience --- Medical sciences --- Diseases --- Endocrinology . --- Neurology .
Choose an application
Impairment of orexin/hypocretin signaling causes narcolepsy-cataplexy in animals and humans. Most human narcolepsy-cataplexy cases are associated with orexin/hypocretin ligand deficiency, which can be detected clinically using cerebrospinal orexin/hypocretin measures and may lead to future treatments with orexin/hypocretin replacement therapy. In The Orexin/Hypocretin System: Physiology and Pathophysiology, leading researchers and clinicians review these exciting developments to set the stage for further research on the loss of orexin/hypocretin neurons in humans, regulation of sleep and wakefulness by the orexin/hypocretin system, and the role of the orexin/hypocretin system in many other physiological processes, including feeding, autonomic regulation, and neuroendocrine regulation. Topics of interest include an assessment of the functions and the physiology of orexin/hypocretin, its pathophysiology in human narcolepsy-cataplexy, and possible pharmacological treatments. The authors also introduce several experimental methods for orexin/hypocretin research, and, using multidisciplinary approaches, explain their uses and limitations. Authoritative and state-of-the-art, The Orexin/Hypocretin System: Physiology and Pathophysiology will aid scientists in the search for novel bioactive peptides and their receptors, as well as novel physiological insights and opportunities for the clinical treatment of not only narcolepsy, but also a broad range of diseases associated with endocrine, feeding, and body weight regulation.
Narcolepsy. --- Orexins. --- Orexins --- Narcolepsy --- Disorders of Excessive Somnolence --- Peptides --- Receptors, Neurotransmitter --- Receptors, Peptide --- Nerve Tissue Proteins --- Receptors, Cell Surface --- Amino Acids, Peptides, and Proteins --- Proteins --- Sleep Disorders, Intrinsic --- Chemicals and Drugs --- Membrane Proteins --- Dyssomnias --- Sleep Disorders --- Nervous System Diseases --- Mental Disorders --- Diseases --- Psychiatry and Psychology --- Neuropeptides --- Receptors, Neuropeptide --- Human Anatomy & Physiology --- Medicine --- Health & Biological Sciences --- Neurology --- Animal Biochemistry --- Hypocretins --- Medicine. --- Neurosciences. --- Biomedicine. --- Sleep disorders --- Hypothalamic hormones
Choose an application
Orexins. --- Narcolepsy. --- Hypocretins --- Hypothalamic hormones --- Gelineau's Syndrome --- Narcoleptic Syndrome --- Gelineau Syndrome --- Narcolepsy-Cataplexy Syndrome --- Paroxysmal Sleep --- Gelineau's Syndromes --- Gelineaus Syndrome --- Narcolepsy Cataplexy Syndrome --- Narcolepsy-Cataplexy Syndromes --- Narcoleptic Syndromes --- Sleep, Paroxysmal --- Syndrome, Gelineau --- Syndrome, Gelineau's --- Syndrome, Narcolepsy-Cataplexy --- Syndrome, Narcoleptic --- Syndromes, Gelineau's --- Syndromes, Narcolepsy-Cataplexy --- Syndromes, Narcoleptic --- Hypocretin-1 --- Hypocretin-2 --- Orexin-A --- Orexin-B --- Hypocretin 1 --- Hypocretin 2 --- Orexin A --- Orexin B --- Sleep disorders --- Hypocretin --- Orexin
Choose an application
This volume is intended for neuropharmacologists, psychopharmacologists, pharmacologists, pharmacists, sleep researchers, translational neuroscience researchers, and other basic researchers and clinical scientists interested in an interdisciplinary approach to sleep medicine. The level of the book is aiming at CNS researchers, drug development scientists, basic and clinical sleep researchers, as well as senior medical students and fellows in psychiatry and neurology. Orexin and Sleep provides a unique resource, giving a comprehensive and highly readable summary of the basic concepts in orexin biology and pharmacology along with clinical applications in sleep medicine in general, and narcolepsy in particular.
Pharmacy, Therapeutics, & Pharmacology --- Health & Biological Sciences --- Orexins. --- Sleep. --- Sleeping --- Slumber --- Hypocretins --- Medicine. --- Molecular biology. --- Neurochemistry. --- Pharmacology. --- Neurology. --- Psychopharmacology. --- Biomedicine. --- Pharmacology/Toxicology. --- Molecular Medicine. --- Health --- Psychophysiology --- Rest --- Sleep-wake cycle --- Subconsciousness --- Dreams --- Hypnagogia --- Hypothalamic hormones --- Toxicology. --- Behavioral pharmacology --- Drugs --- Chemotherapy --- Pharmacology --- Psychotropic drugs --- Medicine --- Nervous system --- Neuropsychiatry --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Biochemistry --- Neurosciences --- Chemicals --- Poisoning --- Poisons --- Psychotropic effects --- Diseases --- Toxicology --- Health Workforce --- Neurology . --- Molecular biochemistry --- Molecular biophysics --- Biophysics --- Biomolecules --- Systems biology --- Drug effects --- Medical pharmacology --- Pharmacy --- Physiological effect
Choose an application
This issue of Current Topics in Behavioral Neuroscience focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians.
Medicine. --- Neurosciences. --- Pharmacology. --- Neurology. --- Pain medicine. --- Psychopharmacology. --- Behavioral sciences. --- Biomedicine. --- Pharmacology/Toxicology. --- Behavioral Sciences. --- Pain Medicine. --- Orexins. --- Neuropsychology. --- Neural sciences --- Neurological sciences --- Neuroscience --- Hypocretins --- Medical sciences --- Nervous system --- Neurophysiology --- Psychophysiology --- Hypothalamic hormones --- Behavioral pharmacology --- Drugs --- Chemotherapy --- Pharmacology --- Psychotropic drugs --- Medicine --- Neuropsychiatry --- Drug effects --- Medical pharmacology --- Chemicals --- Pharmacy --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Pathology --- Physicians --- Psychotropic effects --- Diseases --- Physiological effect --- Toxicology. --- Animal behavior. --- Animals --- Animals, Habits and behavior of --- Behavior, Animal --- Ethology --- Animal psychology --- Zoology --- Ethologists --- Psychology, Comparative --- Poisoning --- Poisons --- Behavior --- Toxicology --- Neurology . --- Algiatry
Listing 1 - 5 of 5 |
Sort by
|